Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2004
03/25/2004WO2003076472A3 Neoplasm specific antibodies and uses thereof
03/25/2004WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
03/25/2004WO2003074674A3 MSRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
03/25/2004WO2003073935A8 Breath collection system
03/25/2004WO2003072806A3 Modification of bioassays for detection of antigen characteristic of bacteria that are causative of ear and respiratory infections in children
03/25/2004WO2003072804A3 Nanostructures containing pilin protein
03/25/2004WO2003072060A3 Polypeptide formulation
03/25/2004WO2003069338A3 Analysis of vital substances
03/25/2004WO2003068944A3 METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α-
03/25/2004WO2003068914A3 Solution structure of rip dd and uses therof
03/25/2004WO2003068712A3 Novel method for production of dna biochips and applications thereof
03/25/2004WO2003056340A3 Fadd proteins, phosphorylated p38-mapk and fasl as tumour markers
03/25/2004WO2003055443A3 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
03/25/2004WO2003054156A3 Novel g proein-coupled receptor, gave7
03/25/2004WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof
03/25/2004WO2003046578A3 Method for the assessment and prognosis of sarcoidosis
03/25/2004WO2003040315A3 Method of encoding characteristics of a biological sample
03/25/2004WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
03/25/2004WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor
03/25/2004WO2003038394A3 Device and method for determining the quality a medium, particularly of a lubricant and/or coolant
03/25/2004WO2003033680A3 Kinases and phosphatases
03/25/2004WO2003032138A3 Device having touch sensitivity functionality
03/25/2004WO2003025128A3 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
03/25/2004WO2003020887A3 Gene identification
03/25/2004WO2003014745A3 Method for identifying anti-inflammatory drugs
03/25/2004WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
03/25/2004WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use
03/25/2004WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer
03/25/2004WO2003006103A3 Electrical field stimulation of eukaryotic cells
03/25/2004WO2002102829A3 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
03/25/2004WO2002101070A3 Alpha 2 integrin: modulators of lymphocyte activation
03/25/2004WO2002099438A3 Modulation of steroid hormone uptake
03/25/2004WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof
03/25/2004WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
03/25/2004WO2002088702A3 Dielelectrophoretic method and apparatus for high throughput screening
03/25/2004WO2002085093A3 Replikin peptides and uses thereof
03/25/2004WO2002083859A8 Surface proteins of streptococcus pyogenes
03/25/2004WO2002079492A8 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
03/25/2004WO2002074048A3 P-glycoproteins and uses thereof
03/25/2004WO2002063006A3 Receptors and membrane-associated proteins
03/25/2004WO2002059321A3 Hepatitis c virus replicons and replicon enhanced cells
03/25/2004WO2002057789A8 Test for transmissible spongiform encephalopathies
03/25/2004WO2002057496A3 Gene expression profiling of endothelium in alzheimer's disease
03/25/2004WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
03/25/2004WO2002014862A8 Method and device for characterising and/or for detecting a bonding complex
03/25/2004WO2001051007A3 Nuclear packing efficiency
03/25/2004US20040059522 Method for partitioned layout of protein interaction networks
03/25/2004US20040059521 Method for visualizing large-scale protein interaction data
03/25/2004US20040059519 Multiplexed analysis of clinical specimens apparatus and methods
03/25/2004US20040059509 Method and apparatus for determining moisture content and conductivity
03/25/2004US20040059239 Apparatus and method for non-invasively measuring cardiac output
03/25/2004US20040059207 Ocular analyte sensor
03/25/2004US20040059201 Apparatus and method for monitoring blood glucose levels including convenient display of blood glucose value average and constituent values
03/25/2004US20040059096 Immunoglobulin for preventing shellfish poisoning
03/25/2004US20040058884 Detecting diseases by Selex method; anticancer agents
03/25/2004US20040058869 Methods and reagents for modulating cholesterol levels
03/25/2004US20040058868 Using insulin receptor substrate and histone deacetylase inhibitor; regenerating insulin sensitivity
03/25/2004US20040058862 Novel polypeptides and nucleic acids encoding the same
03/25/2004US20040058853 Multivalent neuraminidase inhibitor conjugates
03/25/2004US20040058851 Specific autoimmune reactions against isomerised/optically inverted epitopes: application for diagnosis of autoimmune diseases
03/25/2004US20040058844 High density fine powder immobilization on substrate; controlling surface tension; Dna, oligonucleotide chips
03/25/2004US20040058458 Modulated chemical sensors
03/25/2004US20040058457 Nucleic acid nanoparticle complex comprising peptide ligand for use electronic, optics, genomics, proteomics, and biomedical analysis; microarray chips
03/25/2004US20040058456 Method of coupling binding agents to a substrate surface
03/25/2004US20040058455 Optical detection apparatus comprising a plurality of colloidal particles assembled into array for monitoring large numbers of disparate environmental stimuli concurrently
03/25/2004US20040058454 Detection of allergen-associated materials
03/25/2004US20040058453 Reaction pouch comprising an analytical sensor
03/25/2004US20040058451 Automated flocculation titrimeter system
03/25/2004US20040058444 Bioprosthetic heart valves
03/25/2004US20040058438 Dispensing device, dispensing method and method of detecting defective discharge of solution containing biological sample
03/25/2004US20040058433 Metal electrodes has a surface that is modified with a surface modification layer made up of linera molecules having sufhydryl end group and a sulfonate end group separated by lower alkyl linking group
03/25/2004US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/2004US20040058423 Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis
03/25/2004US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/2004US20040058406 Assay methods and systems
03/25/2004US20040058405 Methods of assessing wolframin protein activity
03/25/2004US20040058404 Method for examining caries risk
03/25/2004US20040058401 Identifying cellular changes associated with cell proliferation disorders
03/25/2004US20040058399 Evaluating effectiveness of isoniazid preventive therapy in treating tuberculosis
03/25/2004US20040058398 Pancreatic progenitor cells and methods for isolating the same
03/25/2004US20040058396 Methods for the screening of non-recombinant cell lines capable of expressing a single PDE4 isoenzyme and for the screening of PDE4 inhibitors
03/25/2004US20040058395 Method of diagnosing nephropathy
03/25/2004US20040058392 Use of novel stem cell markers for isolation of intestinal stem cells, and use of the intestinal stem cells thus obtained for the preparation of a therapeutical composition
03/25/2004US20040058391 Microarray comprising layered frameworks for use in parallel synthesis of libraries of peptides, oligonucleotides and general organic compounds; drug screening
03/25/2004US20040058390 Contacting a polypeptide with an ester or thioester group, with an anchor molecule containing two nucleotphilic group at meta or ortho positions to each other, trans-esterification of ester/thiosester with nucleotphilic group
03/25/2004US20040058389 Electrochemical detection of specific binding pairs utilizing polystyrene encapsulated hydrophobic nano-metallocene markers
03/25/2004US20040058388 Quality assurance/quality control for high throughput bioassay process
03/25/2004US20040058387 Immunoglobulin microarray for detection and measurement of hemoglobin a1c (HBA1C) concentrations; diagnosing and controlling diabetes
03/25/2004US20040058385 Kit and method for determining multiple analytes, with provisions for refrencing the density of immobilised recognition elements
03/25/2004US20040058384 Ion-detecting microspheres and methods of use thereof
03/25/2004US20040058383 Using concentration of human luteinizing hormone (hLH) to prognose and predict onset of menopause; evaluating efficacy of hormone replacement therapy
03/25/2004US20040058382 Measurement of the elastin-specific amino acids, desmosine and isodesmosine, in sputum to determine the lung disease in a human, such as pulmonary emphysema, using chromatography, spectroscopy and immunoassay
03/25/2004US20040058381 Microcapsule biosensors and methods of using the same
03/25/2004US20040058380 Co-adsorbing monomers (of polysilane polymer) and template molecules on a support surface, polymerizing the monomers, while template molecule adsorbed on the support surface, removing template from the sensor's surface
03/25/2004US20040058379 Tumor suppressor gene, p47Ing3
03/25/2004US20040058372 Initializing control model for monitoring spectral data from bioinformatics system
03/25/2004US20040058368 M-GAL: a Gal gene switch-based suite of methods protein analyses and protein expression in multicellular organisms and cells therefrom
03/25/2004US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders
03/25/2004US20040058359 Erbin as a negative regulator of Ras-Raf-Erk signaling
03/25/2004US20040058358 Lipid metabolism transcription factor